Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaglitazone Dose-Ranging Study in Type 2 Diabetes
NCT00057304Phase 2Completed
- Sponsor
- Roche
- Start
- Jun 2003
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 2, randomised, double-blind trial of edaglitazone in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Roche. Started Jun 2003; status: completed.
02
Drugs
edaglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00057304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057304.